{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:03Z","timestamp":1791583143846,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jacc.2015.02.061","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T14:15:58Z","timestamp":1430748958000},"page":"1915-1928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":317,"title":["Hypertrophic Cardiomyopathy in\u00a0Adulthood Associated With Low\u00a0Cardiovascular Mortality With Contemporary Management Strategies"],"prefix":"10.1016","volume":"65","author":[{"given":"Barry J.","family":"Maron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Rowin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Lesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross F.","family":"Garberich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Udelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.02.061_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.02.061_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","article-title":"Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2012-303271","volume":"99","author":"O\u2019Mahony","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2015.02.061_bib5","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib6","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib7","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib8","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.02.061_bib9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib10","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.112.123174","article-title":"Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease","volume":"126","author":"Maron","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/europace\/eup431","article-title":"Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers","volume":"12","author":"Christiaans","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2015.02.061_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.02.061_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2015.02.061_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ahj.2013.06.009","article-title":"Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications","volume":"166","author":"Vriesendorp","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.02.061_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of\u00a0implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.02.061_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"11","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCHEARTFAILURE.109.922872","article-title":"Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy","volume":"3","author":"Maron","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2015.02.061_bib18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.amjcard.2012.04.030","article-title":"Cardiac transplantation in patients with hypertrophic cardiomyopathy","volume":"110","author":"Kato","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy\u00a0\u2265 60 years of age","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib20","unstructured":"Dutchen S. Silencing Sudden Death. Harvard Medical School News. October 3, 2013. Available at: http:\/\/hms.harvard.edu\/news\/genetics\/silencing-sudden-death-10-3-13. Accessed March 6,\u00a02013."},{"key":"10.1016\/j.jacc.2015.02.061_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib22","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcmg.2013.08.010","article-title":"Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes","volume":"7","author":"Desai","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2015.02.061_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib25","series-title":"Vital Statistics of the United States, 1995, preprint of volume II, Mortality, part A, section 6 Life Tables","year":"1998"},{"key":"10.1016\/j.jacc.2015.02.061_bib26","series-title":"Modeling Survival Data: Extending the Cox Model","first-page":"16","author":"Therneau","year":"2000"},{"key":"10.1016\/j.jacc.2015.02.061_bib27","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","article-title":"Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors","volume":"113","author":"Spirito","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjcard.2007.09.101","article-title":"Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status","volume":"101","author":"Maron","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib30","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.jacc.2011.03.021","article-title":"Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy","volume":"57","author":"Maron","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib32","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib33","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib34","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/adc.59.10.971","article-title":"Hypertrophic cardiomyopathy: an important cause of sudden death","volume":"59","author":"McKenna","year":"1984","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jacc.2015.02.061_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.CIR.53.1.9","article-title":"Asymmetric septal hypertrophy in childhood","volume":"53","author":"Maron","year":"1976","journal-title":"Circulation"},{"issue":"Suppl II","key":"10.1016\/j.jacc.2015.02.061_bib36","first-page":"179","article-title":"The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy","volume":"35","author":"Shah","year":"1974","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2015.02.061_bib37","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0140-6736(73)92730-X","article-title":"Prognosis and mortality of hypertrophic obstructive cardiomyopathy","volume":"2","author":"Hardarson","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.02.061_bib38","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM198903233201201","article-title":"Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population","volume":"320","author":"Spirito","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.02.061_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.02.061_bib40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jacc.2014.12.004","article-title":"Hypertrophic cardiomyopathy: can the horse be put back in the barn?","volume":"65","author":"Wheeler","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.02.061_bib42","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.02.061_bib43","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.02.061_bib44","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.02.061_bib45","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1540-8167.2008.01147.x","article-title":"Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy","volume":"19","author":"Maron","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib46","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.02.061_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.107.691378","article-title":"Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.061_bib48","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.amjcard.2013.06.040","article-title":"Contemporary surgical management of hypertrophic cardiomyopathy, the need for more myectomy surgeons and disease-specific centers, and the Tufts initiative","volume":"112","author":"Maron","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.02.061_bib49","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.amjcard.2009.05.064","article-title":"Hypertrophic cardiomyopathy centers","volume":"104","author":"Maron","year":"2009","journal-title":"Am J Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715014175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715014175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T03:03:15Z","timestamp":1549767795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109715014175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":49,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0735109715014175"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.02.061","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertrophic Cardiomyopathy in\u00a0Adulthood Associated With Low\u00a0Cardiovascular Mortality With Contemporary Management Strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.02.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}